摘要
目的研究过氧化物酶体增生物活化受体(PPARγ)和维甲类X受体(RXRα)在人类白血病细胞(HL-60、K562、U937)中的表达及其对配体作用的反应。方法采用MTT法检测细胞生长;半定量RT-PCR法检测PPARγ和RXRα mRNA的表达。结果PPARγ和RXRα在HL-60细胞中有较强表达,在K562、U937细胞中表达较弱。PPARγ的配体土槿乙酸(PLAB)能显著抑制3株细胞的生长,PLAB与RXRα的配体9-顺式维甲酸(9-cisRA)联合作用时,与PLAB单独作用比较,对受体高表达的HL-60细胞抑制作用增强较明显(P〈0.05),但对K562、U937的作用增强不明显(P〉0.05)。PLAB和9-cisRA分别上调HL-60细胞PPARγ和RXRα的表达,且联合作用组显著高于单独作用组(P〈0.05)。结论在HL-60、K562、U937细胞中,HL-60细胞PPARγ和RXRα表达最强,这对配体发挥作用可能是必需的,配体发挥的抑制细胞生长的效应可能与其介导的信号途径有关。
Objective To investigate the relationship between the expression of peroxisome proliferators-activated recepter-γ (PPARγ) and retinoid X receptor-α (RXRα) and the inhibitory effect of PLAB, ligand of PPARγ and 9-cisRA, ligand of RXRα on growth of human leukemia cell lines (HL-60, K562 and U937) in vitro. Methods The antiproliferative effect was evaluated by MTT assay. The mRNA expression of PPARγ and RXRα was semi-quantified by RT-PCR. Results PPARγ and RXRα mRNA was both expressed in HL-60, K562 and U937 cells, and the expression in HL-60 was significantly higher than that in K562 and U937. The significant inhibitory effect on the growth of HL-60 cells was observed in K562 and U937 cells. The combination group showed more inhibitory effect in HL-60 cells than PLAB alone(P 〈0.05). PLAB significantly up-regulates the expression of PPARγ in HL-60 cells, the expression of PPARγ and RXRα were higher in combination group than PLAB alone (P 〈0.05). Conclusion The expression of PPARγ and RXRα in HL-60, K562 and U937 cell lines predicts their response to PLAB and 9-cisRA treatment, and the inhibitory effect is different in these three kinds of cell lines, which may be related to their ligands - mediated signal pathway.
出处
《白血病.淋巴瘤》
CAS
2009年第3期131-133,共3页
Journal of Leukemia & Lymphoma
基金
基金项目:国家自然科学基金(30171108)